Osteolytic sarcoidosis of the orbit without pulmonary involvement.

Autor: Gallo RA; Department of Oculoplastic Surgery, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA., Zhang MG; Department of Oculoplastic Surgery, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA., Abou Khzam R; Department of Pathology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA., Tang VD; Department of Pathology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA., Dubovy SR; Department of Pathology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA., Rong AJ; Department of Oculoplastic Surgery, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA.
Jazyk: angličtina
Zdroj: Orbit (Amsterdam, Netherlands) [Orbit] 2023 Oct; Vol. 42 (5), pp. 548-552. Date of Electronic Publication: 2022 Mar 21.
DOI: 10.1080/01676830.2022.2042826
Abstrakt: A 69-year-old woman with a history of a left orbital mass presented to the emergency room with progressive breakthrough pain in her left orbit despite medical therapy. On examination, there was extraocular motility restriction with diplopia upon left supraduction. Computed tomography (CT) scan of the orbits revealed soft tissue thickening of the left medial and superior periorbita and left lacrimal fossa; bony erosion of the left frontal bone, left orbital roof, and left lamina papyracea; and bilateral mass-like enlargement of the extraocular muscles. An orbitotomy with incisional biopsy was performed, and histopathological examination revealed non-caseating granulomatous inflammation consistent with sarcoidosis. Chest imaging demonstrated no sequela of pulmonary sarcoidosis, and her serum angiotensin converting enzyme (ACE) level was within normal range. She was treated with high-dose oral steroids with resolution of her symptoms. Her pain returned at the conclusion of the steroid taper, and it was controlled with chronic subcutaneous methotrexate and adalimumab injections.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje